All men with suspected prostate cancer should be offered a specialist MRI scan when they’re referred to the hospital in England, before a biopsy.
And it’s a decision that prostate cancer expert Professor Mark Emberton is extremely happy about.
Read the original article at: https://scienceblog.cancerresearchuk.org/2019/05/09/prostate-cancer-mri-scans-is-the-nhs-ready/
Read about this week News Digest's cancer research breakthrough headlines including National screening programs, a new drug for aggressive childhood brain cancer, HPV vaccination in Rwanda, and more.
Original article at: https://scienceblog.cancerresearchuk.org/2019/05/11/news-digest-nhs-staff-shortages-hpv-vaccine-in-rwanda-prostate-cancer-guidelines-and-sunscreen-chemicals/
A dual kinase inhibitor* is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine as part of Cancer Research UK’s Combinations Alliance. The novel combination of drugs targets the process of nerve invasion, observed in over 80% of pancreatic ductal adenocarcinoma…
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment. They say the decision will benefit approximately 2,100 patients a year.
Read more at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2019-05-17-cancer-drug-approved-for-nhs-use-in-england-gives-some-multiple-myeloma-patients-another-option
(Hong Kong, April 13, 2015) Prof. Mingjie Zhang of Hong Kong University of Science and Technology, a scientist supported by the Asian Fund for Cancer Research (AFCR), recently discovered a critical molecular interaction governing epithelial cell polarity – a crucial factor in…
Anne Li September 27th, 2015
Omega-3 fatty acids, in particular the long-chain fats eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) found abundantly in oily fish,…